Clinical Cancer Research, Vol 2, Issue 10 1781-1785, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma

M Furihata, T Ishikawa, A Inoue, C Yoshikawa, H Sonobe, Y Ohtsuki, K Araki and S Ogoshi
Departments of Pathology II and Surgery I and II, Kochi Medical School, Nankoku, Kochi 783, Japan.

The expression of cyclin A protein was retrospectively investigated in 124 patients with human esophageal squamous cell carcinoma with immunohistochemical techniques using antibody to cyclin A protein (BF683). Of 124 tumors, 49 (39.5%) exhibited positive staining in cancer cells with this antibody. Staining was observed predominantly but not exclusively in the nucleus. A significantly higher degree of association of immunoreactivity with this antibody was detected for advanced types of tumors (stages I, II, III, and IV) than for early tumors (stage 0; P < 0.05). Patients with cyclin A immunopositivity had a significantly poorer survival rate than did other patients (P < 0.01). These findings provide the first evidence for frequent and unscheduled overexpression of cyclin A protein in human esophageal cancer and suggest the possibility that alteration of cyclin A overexpression is associated with tumor progression and patient prognosis for esophageal cancers.

This article has been cited by other articles:

				M. Yasunaga, Y. Tabira, K. Nakano, S. Iida, N. Ichimaru, N. Nagamoto, and T. Sakaguchi Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma Ann. Thorac. Surg., November 1, 2000; 70(5): 1634 - 1640. [Abstract] [Full Text] [PDF]